Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

CVS Health stock rose after the healthcare provider posted quarterly earnings Wednesday and announced two key leadership ...

CVS Health will report third-quarter earnings before the market opens Wednesday as the pharmacy and health-care provider ...

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Shares of CVS Health Corp. CVS shed 7.37% to $57.07 Thursday, on what proved to be an all-around mixed trading session for ...

CVS Health also revised its profit forecast downward for the ... which pressures profitability. The stock is down 22% year-to ...

Shares of CVS Health Corp. CVS rallied 1.26% to $55.34 Tuesday, on what proved to be an all-around favorable trading session ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare sector. Learn more on CVS stock here.

CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

In addition to the top- and bottom-line results, CVS Health cut its full-year profit outlook for a third consecutive quarter, ...